Introduction {#sec1_1}
============

Muscle mass decreases by 1-2% each year in middle-aged adults \[[@B1],[@B2]\]. The loss of muscle strength amounts to approximately 1.5% each year between 50 and 60 years of age, and increases to 3% per year thereafter. Thus, marked declines in muscle mass and strength have already occurred by middle age, and persons in any age group must protect themselves against the loss of muscle associated with weight loss.

Abdominal obesity, particularly visceral fat accumulation, is an independent risk factor for metabolic and cardiovascular disorders \[[@B3],[@B4]\]. Energy restriction-induced weight loss, which is the most common method of treating obesity and visceral adiposity, can be successful in achieving moderate weight loss \[[@B5]\]. However, energy restriction not only results in the loss of body fat mass but also causes a significant loss of fat-free mass (FFM) \[[@B5],[@B6]\]. This suggests that energy restriction-induced weight loss actually accelerates the loss of muscle mass with age, also known as sarcopenia, which induces physical frailty and increases the risk of cardiovascular diseases \[[@B7]\]. This may result in the decline of both activities of daily living and health-related quality of life. Therefore, it is essential to carefully consider the clinical approach used to treat obesity and visceral adiposity.

Chomentowski et al. \[[@B6]\] reported that the addition of moderate aerobic exercise to intentional diet-induced weight loss attenuated the loss of muscle mass in older, overweight to obese adults. However, Asian populations are more prone to visceral adiposity and low skeletal muscle mass compared to their Western counterparts \[[@B8]\]. Despite these findings, it is unclear whether exercise could help to maintain skeletal muscle mass during energy restriction in Asian (Japanese) individuals with visceral adiposity. Thus, the purpose of this study was to determine whether diet-induced weight loss plus aerobic exercise has beneficial effects on decreasing abdominal fat and metabolic parameters (circulating glucose, lipid, and inflammatory markers) and attenuates the loss of skeletal muscle mass associated with energy restriction in adults with visceral adiposity.

Methods {#sec1_2}
=======

Participants {#sec2_1}
------------

Males and females aged 40-75 years were recruited by advertisements in newspapers, on television, and on public transportation. Overall, 146 subjects were contacted to be participants, and 89 subjects were eligible to be enrolled in the Metabolic Syndrome Prevention/Improvement Intervention Program. Before baseline measurements, subjects were randomized to receive one of two interventions, each lasting 12 weeks: diet-induced weight loss (DO; n = 45) or diet-induced weight loss combined with aerobic exercise (D/Ex; n = 44). The participants enrolled in this study i) had visceral adiposity (visceral fat area ≥ 100 cm^2^), ii) were not taking any medications affecting glucose metabolism to avoid potential confounding effects on weight change, and iii) had no thyroid disease. Of the 14 subjects who did not complete the program (DO: n = 3; D/Ex: n = 11), 5 left for employment-related reasons, 4 had a metabolic disorder or ileus, 2 were lost to follow-up, 2 had poor physical condition during the 12-week intervention, and 1 left for family reasons. Thus, 75 males and females completed the 12-week intervention, with 42 in the DO group (18 males and 24 females) and 33 in the D/Ex group (13 males, 20 females). As a result, the present study only analyzed data from participants who completed the measures at both baseline and at the end of the study. The characteristics of the subjects who completed the intervention were not significantly different between the groups regarding age, male:female ratio, anthropometric variables, or metabolic parameters at baseline. All subjects gave informed consent after agreeing with the purpose, methods, and significance of the study. This study was approved by the Ethics Committee of Fukuoka University.

Exercise Protocol {#sec2_2}
-----------------

Participants were instructed to perform 20 min each of step exercises, bicycle ergometry, and walking or running (60 min per session) three times per week under the supervision of exercise trainers. They were also instructed to carry out a further 120 min of exercise per week on their own at home in order to ensure a total of ≥300 min of moderate exercise per week. The exercise intensity was set at lactate threshold (LT). The LT intensity of bicycle ergometer training (W) was determined from an incremental exercise test on a bicycle ergometer, as described below. The LT intensity of step exercise was determined by using a submaximal graded step test \[[@B9]\]. The intensity of walking or jogging was controlled by heart rate (HR) at the LT intensity, which was determined by the step exercise test. HR was measured using a HR monitor (Polar FT1; Polar Electro, Kempele, Finland). The exercise sessions completed at the participant\'s homes (stepping and walking or jogging) were performed using provided bench steps and HR monitors. Each participant recorded all exercise sessions, including the duration (min), mode, and HR, which were reviewed every other week to assess exercise adherence. All subjects underwent workload modifications at least 6 weeks after starting the program. According to the participant\'s diary (exercise duration and body weight (BW)) and exercise intensity (metabolic equivalent (MET)) at the prescribed LT, the estimated energy expenditure per day (kcal/day) during exercise was calculated using the following formula \[[@B10]:\] 'BW (kg) × (MET value − 1 MET) × exercise duration (h/day).' The maximum HRs were calculated using the formula proposed by the American College of Sports Medicine (ACSM) \[[@B11]\]: HRmax = 206.9 -- (0.67 × age).

Energy Restriction {#sec2_3}
------------------

Daily energy needs were determined by multiplying the participant\'s ideal BW equivalent of a BMI of 22 kg/m^2^ by 25. The participants received weekly guidance from skilled dieticians (face-to-face) who recommended appropriate daily nutrition using lectures and counseling. The sessions included adjustments of caloric intake and behavioral therapy. Food diaries were reviewed every week, and participants were given instruction on food intake based on the prescribed energy intake. The participants were instructed to measure their weight daily.

Dietary Records {#sec2_4}
---------------

To calculate energy intake (in kcal) and the intake of fat, protein, and carbohydrate (in grams), each participant completed a self-recorded food intake diary before and at 10-12 weeks following the intervention. Subjects were asked to record food intake over 3 days, including 2 weekdays and either a Saturday or a Sunday. All meals were to be photographed to increase the accuracy of the measurement. Skilled dieticians analyzed the data (table [1](#T1){ref-type="table"}).

Physical Activity {#sec2_5}
-----------------

Physical activity (step count) was measured using a small uniaxial accelerometer (Lifecorder Ex; Suzuken Co., Ltd., Nagoya, Japan) \[[@B12]\]. Subjects wore the accelerometer, except while sleeping or bathing, for 2 weeks before the intervention and during the 10-12 weeks of the intervention. The accelerometer was sealed so that the subjects could not gain access to the physical activity measurements. All measured variables were averaged over the last 7 days of the measurement period to assess physical activity in free-living conditions.

Anthropometric Measurements and Body Composition {#sec2_6}
------------------------------------------------

All anthropometric measurements and body composition were conducted after a fast lasting more than 12 h. BW was measured to the nearest 0.01 kg using electronic scales (Shinko Denshi Vibra Co., Ltd., Tokyo, Japan). Height was measured to the nearest 0.1 cm using a stadiometer. BMI was calculated as kg/m^2^. Body composition was measured using the underwater weighing method, and body density was estimated after correction for residual air by the O~2~ re-breathing method during underwater weighing \[[@B13]\]. Body fat percentage was calculated using the formula of Brozek et al. \[[@B13]\]. Fat mass (FM) and FFM were calculated using the formula 'BW × body fat percentage / 100' and 'BW -- FM'.

Computed Tomography {#sec2_7}
-------------------

Computed tomography (CT) scans were performed as previously described \[[@B14]\]. Visceral fat area (VFA) and subcutaneous fat area (SFA) were assessed at the L4-L5 intervertebral disc space. CT was also used to measure the cross-sectional area (CSA) of the mid-thigh muscle in both legs. Low-density muscle area (LDMA), a marker of lipid-rich skeletal muscle and normal-density muscle area (NDMA), which contains a lower lipid content, were also quantified \[[@B6],[@B15]\]. All subjects fasted for at least 3 h before CT scans but were allowed to drink water.

Blood Biochemistry {#sec2_8}
------------------

Blood samples were obtained from the antecubital vein in the morning after a 12-hour overnight fast. Serum biochemistry analysis was conducted by SRL Inc. (Tokyo, Japan). The biochemical parameters included: interleukin-6 (IL-6), insulin (chemiluminescent enzyme immunoassays), high-sensitive C-reactive protein (hsCRP; nephelometry method), high-molecular-weight adiponectin, TNF-α (enzyme-linked immunosorbent assays), glucose (ultraviolet/hexokinase method), triglyceride (enzyme method), high-density lipoprotein (HDL; direct method), leptin (radioimmunoassays), and hemoglobin A1c (HbA1c; latex agglutination method). HbA1c (%) is presented as the National Glycohemoglobin Standardization Program (NGSP) value, which was calculated using the conversion equation for HbA1c derived by the Japan Diabetes Society (JDS): HbA1c (NGSP; %) = 1.02 × HbA1c (JDS; %) + 0.25% \[[@B16]\]. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as a marker for systemic insulin resistance using the formula reported by Matthews et al. \[[@B17]\]: HOMA-IR = glucose × insulin/405.

Aerobic Work Capacity {#sec2_9}
---------------------

Aerobic work capacity was performed as previously described \[[@B14]\]. The test of aerobic work capacity was continued until subjective exhaustion using a bicycle ergometer (Rehcor; Lode BV, Groningen, The Netherlands) to determine the peak oxygen uptake (VO~2\ peak~). VO~2peak~ was adjusted for FFM.

Statistical Analysis {#sec2_10}
--------------------

All data are presented as means ± standard deviation (SD), and the level of significance for all statistical tests was set at p \< 0.05. hsCRP was logarithmically transformed to approximate a normal distribution. Baseline characteristics were compared between the two groups using unpaired one-way analysis of variance (ANOVA). Repeated-measures ANOVA was used to compare dependent variables as a function of group (DO and D/Ex) and time (pre- and post-intervention). Within-group differences (baseline vs. post-intervention) were assessed by paired t-tests. SPSS version 12.0 (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses.

Results {#sec1_3}
=======

Baseline Data and Intervention Adherence {#sec2_11}
----------------------------------------

There were no significant differences in age, anthropometric parameters, thigh muscle area, or metabolic parameters between the DO and D/Ex groups at baseline. The mean proportion of weekly supervised exercise sessions attended during the 12-week intervention was 81 ± 16%. The mean durations of exercise performed at home and of total exercise were 127 ± 80 min/week and 273 ± 87 min/week, respectively. The percentages of VO~2peak~ at LT (%VO~2\ peak~), predicted maximal HR (%HR~max~), and METs during exercise (prescribed LT intensity) were 55.1 ± 11.9% VO~2peak~, 64.3 ± 9.6% HR~max~, and 5.3 ± 0.8 METs. The estimated energy expenditure attributable to exercise was 263 ± 117 kcal/day. The rates of attendance at nutritional guidance sessions averaged over the 12-week intervention were 97 ± 7% in the DO group and 93 ± 9% in the D/Ex group. In both groups, less than one-third of the subjects achieved the target daily energy intake (DO 33% vs. D/Ex 27%).

Effects of Diet-Induced Weight Loss with or without Aerobic Exercise on Anthropometric Parameters, Aerobic Capacity, Dietary Intake, and Physical Activity {#sec2_12}
----------------------------------------------------------------------------------------------------------------------------------------------------------

There were no significant interaction effects between group and time for the anthropometric parameters (BW, BMI, body fat percentage, FM, FFM, VFA, and SFA) and for dietary intake (table [1](#T1){ref-type="table"}). In addition, decreases in BW, BMI, body fat percentage, FM, FFM, VFA, SFA, and dietary intake were similar in both groups. VO~2\ peak~ increased to a greater extent in the D/Ex group compared with the DO group; the increase from baseline to post-intervention was significant in the D/Ex group, but not in the DO group. The mean step count also increased to a greater extent in the D/Ex group compared with the DO group; the increase from baseline to post-intervention was significant in the D/Ex group, but not in the DO group.

Effects of Diet-Induced Weight Loss with or without Aerobic Exercise on Blood Pressure and Metabolic Parameters {#sec2_13}
---------------------------------------------------------------------------------------------------------------

There was no significant interaction effect between group and time on blood pressure or metabolic parameters. Systolic and diastolic blood pressure decreased in both groups from baseline to post-intervention. In addition, there were significant decreases in glucose, insulin, triglyceride, leptin, hsCRP, HOMA-IR, and HbA1c in both groups. HDL increased significantly and TNF-α decreased significantly in the D/Ex group, but not in the DO group (table [2](#T2){ref-type="table"}).

Percent Changes in BW, FM, FFM, and Thigh Muscle Area {#sec2_14}
-----------------------------------------------------

There was no significant interaction effect between group and time for the percent changes in BW, FM, or FFM. CSA decreased in both groups, although the decrease was greater in the DO group compared with the D/Ex group (fig. [1](#F1){ref-type="fig"}). LDMA, which represents high lipid content, decreased significantly in both groups, without significant differences between the two groups. The decrease in NDMA, which represents lower lipid content, was greater in the DO group compared with the D/Ex group, although the loss of muscle area was only significant in the DO group.

Discussion {#sec1_4}
==========

The main finding of this study was that diet-induced weight loss in addition to aerobic exercise attenuated the loss of thigh skeletal muscle mass associated with energy restriction alone in middle-aged to elderly adults with visceral adiposity. Conversely, diet-induced weight loss alone was associated with reductions in both FFM and thigh skeletal muscle mass. Chomentowski et al. \[[@B6]\] reported that moderate aerobic exercise attenuated the loss of lean muscle mass caused by energy restriction. Diet-induced weight loss that can successfully achieve a weight loss of 5-10% within a short period of time can greatly improve blood pressure as well as glucose and lipid metabolism \[[@B18],[@B19],[@B20]\]. These results suggest that intentional weight loss with diet/energy restriction can improve various metabolic parameters associated with obesity and visceral adiposity but may also increase the risk of sarcopenia, which occurs with aging in association with the loss of muscle \[[@B21],[@B22]\]. Thus, the addition of aerobic exercise to diet-induced weight loss may offer an effective strategy to prevent sarcopenia and may achieve better weight loss compared with diet alone.

The present study indicated that FFM (using the underwater method) decreased in both groups. Previous studies have revealed that the decrease in body mass does not differ between diet- and diet plus exercise-induced weight loss regimens, although diet-induced weight loss reduced FFM (as assessed by dual-energy X-ray absorptiometry (DXA)) more than diet-induced weight loss plus exercise \[[@B6],[@B22]\]. However, an earlier study indicated that 6.8% of FFM was lost during an exercise intervention \[[@B23]\]. This study also suggested that changes in FFM are comparable to changes in appendicular lean soft tissue during energy restriction with or without exercise. The reason for this apparent discrepancy is unclear, but it is possible that differences in methods (DXA vs. underwater method) \[[@B24],[@B25]\] or the composition of the FFM lost (i.e. water, protein, and mineral masses) \[[@B26]\] may be potential explanations.

Interestingly, this study revealed that the improvements in metabolic parameters (including insulin resistance) and the reduction of abdominal fat did not differ between the two groups. Previous studies have also reported that exercise can reduce visceral fat content without inducing weight loss \[[@B27],[@B28]\]. However, Christiansen et al. \[[@B29]\] reported that a relatively large weight loss of ≥5-7% has beneficial effects on the circulating levels of inflammatory markers in obese subjects, whereas aerobic exercise had no effects on these markers. Furthermore, Weiss et al. \[[@B30]\] suggested that the addition of exercise to energy restriction does not appear to have additive effects on changes in metabolic parameters or show improvements in glucose tolerance if exercise training is discontinued for ≥2 days. In the present study, the D/Ex group was assessed 2 days after the last exercise training session to determine the chronic effects of aerobic exercise on metabolic parameters, including insulin resistance. Therefore, the results of the studies described above may be consistent with the current results.

In the present study, there were no significant interaction effects between group and time on dietary intake (p = 0.180). The estimated energy expenditure attributable to exercise in the D/Ex group was 263 ± 117 kcal/day, which would account for a loss of FM of 3.0 ± 1.3 kg over 12 weeks (where 1.0 g of fat equals 7.2 kcal). Nevertheless, the D/Ex group did not lose more weight than the DO group. While there are conflicting reports \[[@B31]\], our results are consistent with those of earlier studies, which indicate that the magnitude of these changes is not substantially different between diet alone and diet plus exercise \[[@B6],[@B22],[@B29]\]. A meta-analysis also suggested that weight loss achieved with diet alone or diet plus exercise is not significantly different (10.7 ± 0.5 vs. 11.0 ± 0.6 kg) \[[@B32]\]. The D/Ex group was instructed to perform ≥300 min of exercise each week; however, this ranged from 199 to 325 min. Therefore, not all participants in this group conducted ≥250 min of exercise per week, which is a threshold level for clinically significant weight loss set by the ACSM \[[@B33]\]. Furthermore, Thomas et al. \[[@B34]\] have reported that the small magnitude of weight loss observed from the majority of evaluated exercise interventions is primarily due to low doses of prescribed exercise energy expenditures compounded by a concomitant increase in caloric intake. This result suggests that the additional effects of diet and exercise are difficult to anticipate, as suggested by the results of previous studies \[[@B6],[@B22],[@B29]\].

Aerobic capacity was clearly increased in the D/Ex group, but not in the DO group. The increase in VO~2\ peak~ in the D/Ex group is an important and clinically relevant outcome. It is well documented that greater aerobic capacity is associated with greater longevity and reduced risks of type 2 diabetes, coronary heart disease, stroke, and colon cancer \[[@B35],[@B36]\]. Aerobic exercise may also benefit aging skeletal muscle by enhancing mitochondrial bioenergetics \[[@B37]\], conferring improvements in insulin sensitivity and/or decreased oxidative stress. Thus, while attenuation of sarcopenia in the thigh muscle is important, the additional benefits of aerobic exercise on increasing aerobic capacity have several clinical implications, including the potential for future increases in activities of daily living and health-related quality of life in middle-aged and older adults. Therefore, our finding that diet-induced weight loss plus aerobic exercise improves aerobic capacity is important in terms of longevity and metabolic disorders.

There are two limitations associated with the present study. Firstly, the sample size was small, included males and females, and the age range was relatively wide. However, the influence of sex as a limitation may be negligible based on the study by Christiansen et al. \[[@B29]\] who found no sex-specific differences of exercise or diet-induced weight loss on metabolic or inflammatory factors, indicating that males and females would respond similarly to a 12-week randomized intervention study. We also found that the decrease in thigh skeletal muscle mass was smaller in the D/Ex group compared with the DO group, even after adjusting for age in ANOVA (DO vs. D/Ex, p = 0.021). Therefore, the age range of subjects is unlikely to affect the results of this study. Secondly, exclusion criteria for the present study included antidiabetic therapy to avoid possible confounding effects on weight change, although subjects receiving antihypertensive and antihyperlipidemic drugs were eligible. However, even if we excluded these participants who were taking such drugs from the analysis, the results were unchanged. Future studies should establish a study protocol for further evaluation (e.g. aerobic training vs. resistance training, and normal diet-induced weight loss vs. high protein diet-induced weight loss with or without exercise).

In conclusion, the present findings suggest that diet-induced weight loss plus aerobic exercise decreases abdominal fat (i.e. visceral and subcutaneous fat) and circulating metabolic parameters, and also attenuates the loss of thigh skeletal muscle mass associated with diet-induced weight loss in middle-aged to elderly adults with visceral adiposity.
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![Percent changes in BW, FM, and FFM (as measured by the underwater method), and thigh muscle area (as measured by CT). Decreases in BW, FM, FFM, and LDMA were similar in both groups. Decreases in CSA and NDMA were greater in the DO group compared with the D/Ex group. \*\*p \< 0.01 and \*\*\*p \< 0.001 versus baseline. ^†^The interaction effect was statistically significant. N.S. = Not significant; DO = diet-induced weight loss only; D/Ex = diet-induced weight loss with aerobic exercise; BW = body weight; FM = fat mass; FFM = fat-free mass; CSA = cross-sectional area; LDMA = low-density muscle area; NDMA = normal-density muscle area.](ofa-0007-0026-g01){#F1}

###### 

Effects of diet-induced weight loss with or without aerobic exercise on anthropometric parameters, aerobic capacity, dietary intake, and physical activity

                                                               DO group        D/Ex group                                        Group × time, p value                                                       
  ------------------------------------------------------------ --------------- ------------------------------------------------- ----------------------- --------------------------------------------------- -------
  Weight, kg                                                   72.2 ± 11.9     67.2 ± 10.1[\*\*\*](#T1F7){ref-type="table-fn"}   71.2 ± 13.7             65.9 ± 12.9[\*\*\*](#T1F7){ref-type="table-fn"}     0.652
  BMI, kg/m^2^                                                 28.0 ± 3.4      26.2 ± 3.0[\*\*\*](#T1F7){ref-type="table-fn"}    27.8 ± 3.8              25.7 ± 3.5[\*\*\*](#T1F7){ref-type="table-fn"}      0.445
  Percentage of body fat, %[^a^](#T1F1){ref-type="table-fn"}   34.2 ± 7.3      31.3 ± 7.7[\*\*\*](#T1F7){ref-type="table-fn"}    34.1 ± 6.4              30.4 ± 6.9[\*\*\*](#T1F7){ref-type="table-fn"}      0.361
  Fat mass, kg[^a^](#T1F1){ref-type="table-fn"}                25.0 ± 6.9      21.3 ± 6.1[\*\*\*](#T1F7){ref-type="table-fn"}    23.8 ± 5.7              19.6 ± 5.4[\*\*\*](#T1F7){ref-type="table-fn"}      0.546
  FFM, kg[^a^](#T1F1){ref-type="table-fn"}                     48.0 ± 9.2      46.7 ± 8.6[\*\*](#T1F6){ref-type="table-fn"}      46.4 ± 10.2             45.1 ± 9.5                                          0.936
  Visceral fat area, cm^2^                                     182 ± 54        151 ± 44[\*\*\*](#T1F7){ref-type="table-fn"}      183 ± 52                140 ± 46^[\*\*\*](#T1F7){ref-type="table-fn"}^      0.104
  Subcutaneous fat area, cm^2^                                 284 ± 108       252 ± 102^[\*\*\*](#T1F7){ref-type="table-fn"}^   281 ± 92                241 ± 90^[\*\*\*](#T1F7){ref-type="table-fn"}^      0.333
  VO~2~ peak, ml/min/kg FFM[^b^](#T1F2){ref-type="table-fn"}   33.0 ± 6.2      31.2 ± 5.3[\*](#T1F5){ref-type="table-fn"}        32.2 ± 5.7              36.0 ± 7.8[\*](#T1F5){ref-type="table-fn"}          0.001
  Step counts, steps/day[^c^](#T1F3){ref-type="table-fn"}      6,645 ± 2,492   7,116 ± 2,902                                     6,602 ± 3,004           9,195 ± 3,711[\*\*\*](#T1F7){ref-type="table-fn"}   0.001
  Energy intake, kcal/day[^d^](#T1F4){ref-type="table-fn"}     2,008 ± 385     1,526 ± 300[\*\*\*](#T1F7){ref-type="table-fn"}   2,000 ± 316             1,618 ± 330^[\*\*\*](#T1F7){ref-type="table-fn"}^   0.180
  Protein, g/day[^d^](#T1F4){ref-type="table-fn"}              75 ± 18         63 ± 13[\*\*\*](#T1F7){ref-type="table-fn"}       82 ± 16                 68 ± 17[\*\*\*](#T1F7){ref-type="table-fn"}         0.822
  Fat, g/day[^d^](#T1F4){ref-type="table-fn"}                  60 ± 15         43 ± 12[\*\*\*](#T1F7){ref-type="table-fn"}       60 ± 15                 47 ± 14[\*\*\*](#T1F7){ref-type="table-fn"}         0.314
  Carbohydrate, g/day[^d^](#T1F4){ref-type="table-fn"}         269 ± 53        211 ± 42[\*\*\*](#T1F7){ref-type="table-fn"}      267 ± 51                224 ± 44[\*\*\*](#T1F7){ref-type="table-fn"}        0.179

DO group = Diet-induced weight loss group; D/Ex group = diet-induced weight loss with aerobic exercise group; FFM = fat-free mass.

DO (n=38), D/Ex (n=32).

DO (n=38), D/Ex (n=31).

DO (n=34), D/Ex (n=29).

DO (n=38), D/Ex (n=30).

Pre vs. post:

p \< 0.05

p \< 0.01

p \< 0.001.

###### 

Effects of diet-induced weight loss with or without aerobic exercise on blood pressure and metabolic parameters

                                                                             DO group     D/Ex group                                        Group × time, p value                                                     
  -------------------------------------------------------------------------- ------------ ------------------------------------------------- ----------------------- ------------------------------------------------- -------
  SBP, mm Hg[^a^](#T2F1){ref-type="table-fn"}                                139 ± 18     131 ± 20[\*\*\*](#T2F9){ref-type="table-fn"}      137 ± 20                129 ± 18[\*\*](#T2F8){ref-type="table-fn"}        0.914
  DBP, mm Hg[^a^](#T2F1){ref-type="table-fn"}                                87 ± 12      82 ± 11[\*\*](#T2F8){ref-type="table-fn"}         84 ± 11                 79 ± 10[\*\*](#T2F8){ref-type="table-fn"}         0.946
  Glucose, mg/dl                                                             103 ± 13     99 ± 10[\*\*](#T2F8){ref-type="table-fn"}         104 ± 13                99 ± 8[\*\*](#T2F8){ref-type="table-fn"}          0.870
  Insulin, μIU/ml                                                            8.6 ± 3.9    6.6 ± 2.7[\*\*\*](#T2F9){ref-type="table-fn"}     10.0 ± 6.1              6.7 ± 3.9[\*\*\*](#T2F9){ref-type="table-fn"}     0.165
  HDL, mg/dl                                                                 52 ± 13      52 ± 14                                           52 ± 13                 54 ± 12[\*](#T2F7){ref-type="table-fn"}           0.096
  Triglyceride, mg/dl[^b^](#T2F2){ref-type="table-fn"}                       149 ± 83     119 ± 68[\*\*](#T2F8){ref-type="table-fn"}        132 ± 61                86 ± 33[\*\*\*](#T2F9){ref-type="table-fn"}       0.249
  Interleukin--6, pg/ml[^c^](#T2F3){ref-type="table-fn"}                     2.3 ± 2.4    1.5 ± 1.3[\*](#T2F7){ref-type="table-fn"}         4.8 ± 13.4              1.8 ± 3.1                                         0.296
  TNF-α, pg/ml[^d^](#T2F4){ref-type="table-fn"}                              1.2 ± 0.6    1.1 ± 0.6                                         1.2 ± 0.5               1.1 ± 0.4[\*\*](#T2F8){ref-type="table-fn"}       0.115
  Leptin, ng/ml                                                              12.4 ± 7.4   8.6 ± 6.7[\*\*\*](#T2F9){ref-type="table-fn"}     11.3 ± 6.2              6.5 ± 3.9[\*\*\*](#T2F9){ref-type="table-fn"}     0.211
  hsCRP[^e^](#T2F5){ref-type="table-fn"},[^f^](#T2F6){ref-type="table-fn"}   2.9 ± 0.5    2.5 ± 0.3^[\*\*\*](#T2F9){ref-type="table-fn"}^   3.0 ± 0.5               2.7 ± 0.5[\*\*](#T2F8){ref-type="table-fn"}       0.230
  High molecular weight                                                      5.0 ± 3.2    5.4 ± 3.1\*                                       4.9 ± 3.1               5.5 ± 3.1[\*\*](#T2F8){ref-type="table-fn"}       0.392
  adiponectin, μg/ml                                                                                                                                                                                                  
  HOMA-IR                                                                    2.3 ± 1.3    1.6 ± 0.7[\*\*\*](#T2F9){ref-type="table-fn"}     2.7 ± 1.9               1.7 ± 1.1[\*\*\*](#T2F9){ref-type="table-fn"}     0.208
  HbA1c, %[^e^](#T2F5){ref-type="table-fn"}                                  5.6 ± 0.4    5.5 ± 0.4[\*\*](#T2F8){ref-type="table-fn"}       5.7 ± 0.5               5.5 ± 0.4^[\*\*\*](#T2F9){ref-type="table-fn"}^   0.315

DO group = Diet-induced weight loss group; D/Ex group = diet-induced weight loss with aerobic exercise group.

DO (n = 40), D/Ex (n = 33).

DO (n = 42), D/Ex (n = 32).

DO (n = 41), D/Ex (n = 31).

DO (n=39), D/Ex (n = 31).

DO (n = 41), D/Ex (n = 33).

hsCRP was logarithmically transformed to approximate a normal distribution.

Pre vs. post:

p \< 0.05

p \< 0.01

p \< 0.001.
